Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-17

Clinical Trial Update: Comparison of Efficacy of Tranexamic Acid Mesotherapy Versus 0.9% Normal Saline for Melasma [Phase 2, Phase 3]

View source ↗

Summary

A phased clinical trial comparing tranexamic acid mesotherapy to normal saline for melasma has completed Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Normal saline (0.9% NaCl) (sodium chloride 0.9%)
  • tranexamic acid mesotherapy (tranexamic acid)

Snippet

Sponsor: Jinnah Postgraduate Medical Centre | Conditions: Effect of Drugs, Adverse Effects of Medical Drugs | Phase 2, Phase 3 | Status: COMPLETED